Patents by Inventor Joyce Tsai

Joyce Tsai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230170075
    Abstract: Systems and methods for implementing an exposure progression that improves an ability of a subject to manage a psychiatric or mental condition of the subject are provided. An exposure progression includes a plurality of categories in a hierarchical order. Each category is associated with one or more experiences, and each experience is associated with a digital reality scene that manifests a challenge. In some embodiments, the hierarchical order is generated or modified dynamically based at least in part on the level of success that a subject has had in one or more challenges, producing an exposure progression that it not only tailored to each subject but also with personalized timing and/or nature of the exposure practice.
    Type: Application
    Filed: December 1, 2022
    Publication date: June 1, 2023
    Applicants: BehaVR, Inc., Sumitomo Pharma Co., Ltd.
    Inventors: Aprilia Alam, Brandon Hedges, Christina Zaluski, Eleanor Anderson, Georgia Mitsi, Joyce Tsai, Morgan Taylor, Risa Weisberg, Sarah Zadd, Todd Grinnell
  • Publication number: 20230056779
    Abstract: Systems and methods for preparing a regimen for improving an ability of a subject to manage a psychiatric or mental condition are provided. A method includes presenting a first digital reality scene with interactive digital chart and bin. The bin includes a plurality of nodes. Each node corresponds to a respective category in a plurality of categories and a plurality of proposed experiences associated with the respective category. Each proposed experience is associated with a unique digital reality scene, different than the first digital reality scene, that manifests a challenge represented by the respective category and/or the respective proposed experience. Each node is also associated with at least one respective gate criterion. A method also includes detecting a selection of a node and placing the node on the chart, thus providing access to the corresponding plurality of proposed experiences associated with the respective category.
    Type: Application
    Filed: July 20, 2022
    Publication date: February 23, 2023
    Applicants: BehaVR, Inc., Sumitomo Pharma Co., Ltd.
    Inventors: Aprilia Alam, Aneth Canale, Todd Grinnell, Brandon Hedges, Georgia Mitsi, Morgan Taylor, Joyce Tsai, Sarah Zadd, Christina Zaluski, Eleanor Anderson
  • Publication number: 20090264522
    Abstract: The present invention relates to a method of treating a central nervous system disorder, such as a mood disorder (e.g., major depressive disorder) or an anxiety disorder (e.g., general anxiety disorder, social anxiety disorder, post traumatic stress disorder, and panic disorder) with a low dose combination of escitalopram and bupropion.
    Type: Application
    Filed: June 23, 2009
    Publication date: October 22, 2009
    Applicant: Forest Laboratories Holdings Limited
    Inventors: Jeffrey Jonas, Anjana Bose, Joyce Tsai
  • Patent number: 7569605
    Abstract: The present invention relates to a method of treating a central nervous system disorder, such as a mood disorder (e.g., major depressive disorder) or an anxiety disorder (e.g., general anxiety disorder, social anxiety disorder, post traumatic stress disorder, and panic disorder) with a low dose combination of escitalopram and bupropion.
    Type: Grant
    Filed: October 16, 2006
    Date of Patent: August 4, 2009
    Assignee: Forest Laboratories Holdings Limited
    Inventors: Jeffrey Jonas, Anjana Bose, Joyce Tsai
  • Publication number: 20070203231
    Abstract: The present invention relates to a method of treating a central nervous system disorder, such as a mood disorder (e.g., major depressive disorder) or an anxiety disorder (e.g., general anxiety disorder, social anxiety disorder, post traumatic stress disorder, and panic disorder) with a low dose combination of escitalopram and bupropion.
    Type: Application
    Filed: October 16, 2006
    Publication date: August 30, 2007
    Applicant: Forest Laboratories, Inc.
    Inventors: Jeffrey Jonas, Anjana Bose, Joyce Tsai